Jillian Caldwell, DO, MS
@jilliancaldwell.bsky.social
Postdoc and clinical nephrologist interested in health policy research. Cat mom to 4. Peloton enthusiast.
Reposted by Jillian Caldwell, DO, MS
RCT: Home-delivered, low-sodium Dietary Approaches to Stop Hypertension (DASH) groceries and dietitian support temporarily improved blood pressure and LDL cholesterol in Black adults with high BP versus monetary support.
#AHA25 @ahascience.bsky.social
ja.ma/4oZ5JVI
#AHA25 @ahascience.bsky.social
ja.ma/4oZ5JVI
November 9, 2025 at 10:25 PM
RCT: Home-delivered, low-sodium Dietary Approaches to Stop Hypertension (DASH) groceries and dietitian support temporarily improved blood pressure and LDL cholesterol in Black adults with high BP versus monetary support.
#AHA25 @ahascience.bsky.social
ja.ma/4oZ5JVI
#AHA25 @ahascience.bsky.social
ja.ma/4oZ5JVI
Congrats to the incoming AJKD editorial interns! Just finished my last editorial call as a 2024-2025 intern and it was such a fantastic experience. Highly recommend to anyone interested in a research career. Very grateful to everyone on the @ajkd.bsky.social editorial board for teaching us so much!
Introducing the 2025-26 AJKD Editorial Interns:
-Elias J. Elenjickal
-Natasha Freeman
-Kashvi Gupta @kashvilunawat.bsky.social
-Ifeoluwa T. Stowe
-Nicole E. Wyatt
Learn more about them on the #AJKDBlog: bit.ly/44y2tcr
-Elias J. Elenjickal
-Natasha Freeman
-Kashvi Gupta @kashvilunawat.bsky.social
-Ifeoluwa T. Stowe
-Nicole E. Wyatt
Learn more about them on the #AJKDBlog: bit.ly/44y2tcr
June 30, 2025 at 8:55 PM
Congrats to the incoming AJKD editorial interns! Just finished my last editorial call as a 2024-2025 intern and it was such a fantastic experience. Highly recommend to anyone interested in a research career. Very grateful to everyone on the @ajkd.bsky.social editorial board for teaching us so much!
Reposted by Jillian Caldwell, DO, MS
Answer:
- in centre HD, of course. But driven by: patient transportation to the unit 3 X week!
#NephSky
Source: @kireports.bsky.social www.ajkd.org/article/S027...
- in centre HD, of course. But driven by: patient transportation to the unit 3 X week!
#NephSky
Source: @kireports.bsky.social www.ajkd.org/article/S027...
June 30, 2025 at 7:38 PM
Answer:
- in centre HD, of course. But driven by: patient transportation to the unit 3 X week!
#NephSky
Source: @kireports.bsky.social www.ajkd.org/article/S027...
- in centre HD, of course. But driven by: patient transportation to the unit 3 X week!
#NephSky
Source: @kireports.bsky.social www.ajkd.org/article/S027...
Reposted by Jillian Caldwell, DO, MS
"How do you figure that out if you’ve just run a large-scale randomized experiment?"
In this Medical News article, economist Susan Athey discusses the effectiveness of machine learning in targeting interventions.
#MedSky
In this Medical News article, economist Susan Athey discusses the effectiveness of machine learning in targeting interventions.
#MedSky
How Machine Learning Could Help Target Nudges
This Medical News article is an interview with Stanford University economist Susan Athey, PhD, about the clinical practice implications of her recent research on machine learning and causal vs predict...
jamanetwork.com
June 18, 2025 at 1:48 PM
"How do you figure that out if you’ve just run a large-scale randomized experiment?"
In this Medical News article, economist Susan Athey discusses the effectiveness of machine learning in targeting interventions.
#MedSky
In this Medical News article, economist Susan Athey discusses the effectiveness of machine learning in targeting interventions.
#MedSky
Reposted by Jillian Caldwell, DO, MS
This #ASNKidneyNews policy update highlights two ongoing reforms in policy and quality programs:
1. Reform to the Centers for Medicare and Medicaid End-Stage Renal Disease Prospective Payment System.
2. Transparency and Medicare Advantage, focusing on quality. kidney.pub/KN1706-07
1. Reform to the Centers for Medicare and Medicaid End-Stage Renal Disease Prospective Payment System.
2. Transparency and Medicare Advantage, focusing on quality. kidney.pub/KN1706-07
June 18, 2025 at 3:00 PM
This #ASNKidneyNews policy update highlights two ongoing reforms in policy and quality programs:
1. Reform to the Centers for Medicare and Medicaid End-Stage Renal Disease Prospective Payment System.
2. Transparency and Medicare Advantage, focusing on quality. kidney.pub/KN1706-07
1. Reform to the Centers for Medicare and Medicaid End-Stage Renal Disease Prospective Payment System.
2. Transparency and Medicare Advantage, focusing on quality. kidney.pub/KN1706-07
Reposted by Jillian Caldwell, DO, MS
Survival advantages of deceased-donor kidney transplantation don't apply to all patients and donor organs, findings presented at #ERA25 suggested. #nephrology #nephsky #kidneytransplant #transplantation www.docwirenews.com/post/limited...
Limited Survival Benefit Seen in Some Patients With Kidney Transplant | Docwire News
Survival benefits of deceased-donor kidney transplantation decrease when older, high-risk patients receive lower-quality organs.
www.docwirenews.com
June 6, 2025 at 9:57 AM
Survival advantages of deceased-donor kidney transplantation don't apply to all patients and donor organs, findings presented at #ERA25 suggested. #nephrology #nephsky #kidneytransplant #transplantation www.docwirenews.com/post/limited...
Reposted by Jillian Caldwell, DO, MS
How do patients select dialysis facilities? Proximity? Quality? Preserving care continuity with their nephrologist?
Our latest in @JAMAHealthForum
suggests patients value proximity and care continuity.
Quality gets sacrificed
🧵(link at end) 1/
Our latest in @JAMAHealthForum
suggests patients value proximity and care continuity.
Quality gets sacrificed
🧵(link at end) 1/
April 11, 2025 at 3:45 PM
How do patients select dialysis facilities? Proximity? Quality? Preserving care continuity with their nephrologist?
Our latest in @JAMAHealthForum
suggests patients value proximity and care continuity.
Quality gets sacrificed
🧵(link at end) 1/
Our latest in @JAMAHealthForum
suggests patients value proximity and care continuity.
Quality gets sacrificed
🧵(link at end) 1/
Reposted by Jillian Caldwell, DO, MS
While health regulations are usually well intentioned they often are poorly implemented
Dialysis is a prime example of regulation perpetuating a consolidated industry with no market competition, poor outcomes &price gouging
New in HealthAffairs Forefront
🧵1/ (link at end)
x.com/Health_Affai...
Dialysis is a prime example of regulation perpetuating a consolidated industry with no market competition, poor outcomes &price gouging
New in HealthAffairs Forefront
🧵1/ (link at end)
x.com/Health_Affai...
April 10, 2025 at 1:38 AM
While health regulations are usually well intentioned they often are poorly implemented
Dialysis is a prime example of regulation perpetuating a consolidated industry with no market competition, poor outcomes &price gouging
New in HealthAffairs Forefront
🧵1/ (link at end)
x.com/Health_Affai...
Dialysis is a prime example of regulation perpetuating a consolidated industry with no market competition, poor outcomes &price gouging
New in HealthAffairs Forefront
🧵1/ (link at end)
x.com/Health_Affai...
Money shot below ⬇️
Compare to pts with FULL rx subsidies (who pay $0), pts with pts with Part D but NO subsidies had 10pp more rx fills, and pts with PARTIAL subsidies had 2pp more rx fills post-TDAPA.
i.e., the more you paid pre-TDAPA, the more meds you filled post-policy
Compare to pts with FULL rx subsidies (who pay $0), pts with pts with Part D but NO subsidies had 10pp more rx fills, and pts with PARTIAL subsidies had 2pp more rx fills post-TDAPA.
i.e., the more you paid pre-TDAPA, the more meds you filled post-policy
Using a difference-in-differences estimator (we used a 2-way fixed effects estimator in an event study), we show close to parallel trajectories among these 4 groups, but a relative increase in calcimimetic access, again based on the generosity of the subsidy
14/
14/
April 19, 2025 at 8:38 AM
Money shot below ⬇️
Compare to pts with FULL rx subsidies (who pay $0), pts with pts with Part D but NO subsidies had 10pp more rx fills, and pts with PARTIAL subsidies had 2pp more rx fills post-TDAPA.
i.e., the more you paid pre-TDAPA, the more meds you filled post-policy
Compare to pts with FULL rx subsidies (who pay $0), pts with pts with Part D but NO subsidies had 10pp more rx fills, and pts with PARTIAL subsidies had 2pp more rx fills post-TDAPA.
i.e., the more you paid pre-TDAPA, the more meds you filled post-policy
I hear that the phos binder roll-out has been painful thus far - but our findings suggest that covering meds under TDAPA *might* actually increase prescription fills, especially for patients subject to high OOP costs under Part D 🤞🏻
I'm cautiously optimistic that this will IMPROVE access to phosphate binders, based on our historical experience with calcimimetics
22/
22/
April 19, 2025 at 8:13 AM
I hear that the phos binder roll-out has been painful thus far - but our findings suggest that covering meds under TDAPA *might* actually increase prescription fills, especially for patients subject to high OOP costs under Part D 🤞🏻
Latest publication! 🚨
TL;DR:
1) MANY patients on dialysis pay high OOP costs for drugs 💸
-- nearly 20% have NO PART D plan
-- 25% have NO rx subsidies
2) Covering calcimimetics in Part B via TDAPA instead of Part D INCREASED rx fills 📈
Check out @eugelin06.bsky.social's 🧵 & our paper ⬇️
TL;DR:
1) MANY patients on dialysis pay high OOP costs for drugs 💸
-- nearly 20% have NO PART D plan
-- 25% have NO rx subsidies
2) Covering calcimimetics in Part B via TDAPA instead of Part D INCREASED rx fills 📈
Check out @eugelin06.bsky.social's 🧵 & our paper ⬇️
April 19, 2025 at 8:08 AM
Latest publication! 🚨
TL;DR:
1) MANY patients on dialysis pay high OOP costs for drugs 💸
-- nearly 20% have NO PART D plan
-- 25% have NO rx subsidies
2) Covering calcimimetics in Part B via TDAPA instead of Part D INCREASED rx fills 📈
Check out @eugelin06.bsky.social's 🧵 & our paper ⬇️
TL;DR:
1) MANY patients on dialysis pay high OOP costs for drugs 💸
-- nearly 20% have NO PART D plan
-- 25% have NO rx subsidies
2) Covering calcimimetics in Part B via TDAPA instead of Part D INCREASED rx fills 📈
Check out @eugelin06.bsky.social's 🧵 & our paper ⬇️
Reposted by Jillian Caldwell, DO, MS
On Monday the Supreme Court hears a case that could strike down the ACA mandate that insurers cover preventive services at no cost to patients.
We found that ~40 million people with private insurance use these free services, including half of enrolled women.
JAMA Health Forum:
ja.ma/3GcUZC6
🩺📊
We found that ~40 million people with private insurance use these free services, including half of enrolled women.
JAMA Health Forum:
ja.ma/3GcUZC6
🩺📊
Use of No-Cost Preventive Services Jeopardized by Kennedy v Braidwood
This cross-sectional study analyzes the use of 10 no-cost preventive services by individuals with employer-sponsored health insurance, which may be threatened by the upcoming Kennedy v Braidwood Supre...
ja.ma
April 17, 2025 at 4:23 PM
On Monday the Supreme Court hears a case that could strike down the ACA mandate that insurers cover preventive services at no cost to patients.
We found that ~40 million people with private insurance use these free services, including half of enrolled women.
JAMA Health Forum:
ja.ma/3GcUZC6
🩺📊
We found that ~40 million people with private insurance use these free services, including half of enrolled women.
JAMA Health Forum:
ja.ma/3GcUZC6
🩺📊
Only 12% of patients receiving dialysis are currently on the transplant wait list. We estimate that over 11,000 additional organs would be needed to increase that number to 18%. ja.ma/4c0MNkj + check out the editorial too!
Thx to my amazing mentors and @kidneyfund.bsky.social for their support.
Thx to my amazing mentors and @kidneyfund.bsky.social for their support.
Kidney Transplant Wait Times Under Waiting List Expansion Scenarios
This decision analytic model evaluates time to kidney transplant under different scenarios of expanding waiting lists, deceased-donor transplants, and living-donor transplants.
ja.ma
April 2, 2025 at 6:22 PM
Only 12% of patients receiving dialysis are currently on the transplant wait list. We estimate that over 11,000 additional organs would be needed to increase that number to 18%. ja.ma/4c0MNkj + check out the editorial too!
Thx to my amazing mentors and @kidneyfund.bsky.social for their support.
Thx to my amazing mentors and @kidneyfund.bsky.social for their support.
Congrats to both of you!!! 👏🏻👏🏻👏🏻
We are excited to announce the 2025 AKF Clinical Scientist in Nephrology (CSN) fellows! Join us in congratulating Dr. Momen Abbasi, a nephrology fellow at the University of Illinois Chicago & Dr. Api Chewcharat, a nephrology fellow at @mgbresearch.bsky.social: www.kidneyfund.org/article/amer...
March 25, 2025 at 4:14 PM
Congrats to both of you!!! 👏🏻👏🏻👏🏻
Reposted by Jillian Caldwell, DO, MS
We are excited to announce the 2025 AKF Clinical Scientist in Nephrology (CSN) fellows! Join us in congratulating Dr. Momen Abbasi, a nephrology fellow at the University of Illinois Chicago & Dr. Api Chewcharat, a nephrology fellow at @mgbresearch.bsky.social: www.kidneyfund.org/article/amer...
March 25, 2025 at 3:02 PM
We are excited to announce the 2025 AKF Clinical Scientist in Nephrology (CSN) fellows! Join us in congratulating Dr. Momen Abbasi, a nephrology fellow at the University of Illinois Chicago & Dr. Api Chewcharat, a nephrology fellow at @mgbresearch.bsky.social: www.kidneyfund.org/article/amer...
Reposted by Jillian Caldwell, DO, MS
#NephMadness 2025: The PodCrawl
buff.ly/p3xR3cg
Podcasts:
- @thecurbsiders.bsky.social
- Life as a Nephrology Professional @nkf-professionals.bsky.social
- GN in Ten
- @rheummadness.bsky.social
- @freelyfiltered.bsky.social
- Poison Lab
- Nephron Segment
- Kidney Chronicles
buff.ly/p3xR3cg
Podcasts:
- @thecurbsiders.bsky.social
- Life as a Nephrology Professional @nkf-professionals.bsky.social
- GN in Ten
- @rheummadness.bsky.social
- @freelyfiltered.bsky.social
- Poison Lab
- Nephron Segment
- Kidney Chronicles
#NephMadness 2025: The PodCrawl
Submit your picks! | @NephMadness |@nephmadness.bsky.social | NephMadness 2025 Over the next couple of weeks, NephMadness 2025 will be popping up on some great podcasts. Keep your eyes and ears o…
buff.ly
March 1, 2025 at 2:12 PM
#NephMadness 2025: The PodCrawl
buff.ly/p3xR3cg
Podcasts:
- @thecurbsiders.bsky.social
- Life as a Nephrology Professional @nkf-professionals.bsky.social
- GN in Ten
- @rheummadness.bsky.social
- @freelyfiltered.bsky.social
- Poison Lab
- Nephron Segment
- Kidney Chronicles
buff.ly/p3xR3cg
Podcasts:
- @thecurbsiders.bsky.social
- Life as a Nephrology Professional @nkf-professionals.bsky.social
- GN in Ten
- @rheummadness.bsky.social
- @freelyfiltered.bsky.social
- Poison Lab
- Nephron Segment
- Kidney Chronicles
Reposted by Jillian Caldwell, DO, MS
Life Years from Transplant (LYFT) is a measure of the predicted difference between the expected lifespan with and without a kidney transplant. This study found that less homogenous metrics with meaningful disaggregation are needed to inform institutional evaluation and policy change. bit.ly/KID0710
January 30, 2025 at 10:04 PM
Life Years from Transplant (LYFT) is a measure of the predicted difference between the expected lifespan with and without a kidney transplant. This study found that less homogenous metrics with meaningful disaggregation are needed to inform institutional evaluation and policy change. bit.ly/KID0710